The pathological complications of atherosclerosis, namely heart attacks and strokes, remain the leading cause of mortality in the Western world. Preceding atherosclerosis is endothelial dysfunction. There is therefore interest in the application of non-invasive clinical tools to assess endothelial function. The flow-mediated dilation (FMD) test is the standard tool used to assess endothelial function. Reduced FMD is an early marker of atherosclerosis and has been noted for its capacity to predict future cardiovascular disease events. This review discusses the measurement of endothelial function using ultrasound, with a focus on the FMD technique.
Introduction
The pathological complications of atherosclerosis, namely heart attacks and strokes, remain the leading cause of mortality in the Western world 1) . Preceding atherosclerosis is endothelial dysfunction [2] [3] [4] . The endothelium comprises a continuous monolayer of cells which separate the vascular wall from the circulation 5) . Disruption of this essential monolayer is thought to occur early in the pathogenesis of cardiovascular disease (CVD). There is therefore interest in the application of non-invasive clinical tools to assess the function and health of this essential monolayer.
The flow-mediated dilation (FMD) test is the standard tool used to assess endothelial function 6, 7) . Reduced FMD is an early marker of atherosclerosis 6) , has been noted for its capacity to predict future CVD events [8] [9] [10] [11] , and an impaired vascular response has also been demonstrated in children as young as 7 years old with familial hypercholesterolemia 12) . This review discusses the measurement of endothelial function, with a focus on the FMD technique.
Vascular Endothelium
From the lumen to the outer wall, all arteries are composed of an intima, media, and adventitia ( Fig. 1) . The adventitia is the outermost layer and is mainly composed of connective tissue that maintains the vessel shape and limits distention. The media is comprised mainly of vascular smooth muscle cells that regulate blood flow by vasoconstriction or vasodilation. The intima is the innermost lining of the vessel and consists of the endothelium and underlying connective tissue.
Vascular endothelial cells essentially have the same characteristics as all the cells of the human body: cytoplasm and organelles surrounding a nucleus and are contained by the cellular membrane. Endothelial cells form a continuous flat monolayer that cover the vascular lumina throughout the arterial tree. The endothelium is mechanically and metabolically strategically located, separating the vascular wall from the circulation and the blood components 5) . The vascular endothelium utilizes autocrine, paracrine, and classical endocrine signaling to promote vascular homeostasis 13) . These cells are capable of producing a variety of agonistic and antagonistic molecules, including vasodilators and vasoconstrictors, pro-coagulants and anti-coagulants, inflammatory and anti-inflammatory, fibrinolytics and anti-fibrinolytics, oxidizing and anti-oxidizing, and many others 13) .
Endothelial Dysfunction and Atherosclerosis
Upsetting the delicate balance of functions performed by the endothelium initiates a number of events that promote atherosclerosis, the precursor to CVD. Although atherosclerosis is commonly described as the presence of plaques that obstruct the lumen of the conduit arteries, endothelial dysfunction precedes plaque formation [14] [15] [16] . Reduced endothelial responses can be observed early in the course of atherogenesis, preceding angiographic or ultrasonic evidence of atherosclerotic plaque 13) . Disruption of the functional integrity of the vascular endothelium plays an integral role in all stages of atherogenesis, ranging from lesion initiation to plaque rupture. Endothelial dysfunction leads to increased permeability to lipoproteins, foam cell formation, T-cell activation, and smooth muscle migration into the arterial wall 16) . The first step in the formation of plaque occurs when an inflammatory response is incited and fatty streaks appear. If these conditions persist, fatty streaks progress and the plaques become vulnerable to rupture.
Stimuli Regulating Endothelial Function
The hemodynamic conditions inside blood vessels lead to the development of superficial stress near the vessel walls, which can be divided into two categories: 1) circumferential stress due to pulse pressure variation inside the vessel, and 2) shear stress [17] [18] [19] . Circumferential stress acts perpendicular to the vessel wall, whereas shear stress acts at a tangent to the wall to create a frictional force at the surface of the endothelium. Circumferential stress applies stress to all layers of the vessel wall (intima, media and adventia), while shear stress is applied principally at the endothelial surface. Shear stress is considered to be the primary stimulus regulating endothelial cell function.
Shear stress is related to the movement of red blood cells close to the endothelial layer (represented by bottom and top arrows in Fig. 2. 1b) . As fluid particles "travel" parallel to the vessel wall, their average velocity increases from a minimum at the wall to a maximum some distance from the wall, resulting in a gradient of velocities that form concentric circles in the lumen of the vessel (Fig. 2. 1a) . This shearing stress therefore acts at a tangent to the wall to create a frictional force at the surface of the endothelium. Although shear stress has a very small magnitude in comparison to circumferential stress, the endothelial cells are equipped with numerous mechanosensors to detect this stress [20] [21] [22] [23] [24] [25] . To maintain physiological levels of vessel wall shear stress, vascular tissues respond to changes in shear stress with acute adjustments in vascular tone (through vasodilation) 26) . Vasodilation reflects alterations in the rate of production of endothe- lial-derived mediators, including nitric oxide (NO), prostacyclin (PGI2) and endothelium-derived hyperpolarizing factor (EHRF), which act locally to modulate vascular smooth muscle tone (Fig. 2) .
Flow-Mediated Dilation Testing
Endothelium-dependent agonists, such as acetylcholine, can be used to induce a dilatory response 27) ; however, such a practice is invasive and often unpractical, especially in clinical settings. Alternatively, the FMD test is a non-invasive method (Fig. 3) . Typically, a pneumatic tourniquet will be placed around the forearm just below the elbow and inflated to a supersystolic blood pressure for 5 minutes. Rapid deflation of the tourniquet instigates increased blood flow (reactive hyperemia) to the oxygen-starved forearm muscles, with a subsequent increase in flow through the upstream brachial artery. The flow-induced increase in shear stress results in vasodilation. FMD is typically expressed as the percentage increase in the artery diameter above baseline. Table 1 provides a list of recommendations to consider when conducting this test.
Ultrasound
Advances in ultrasound technology have had a profound impact on the capacity of researchers and clinicians alike to non-invasively assess endothelial Subject preparation -Fast overnight prior to testing, and avoid exercise during the preceding 24 hrs.
-Refrain from taking drugs with known vascular effects.
-Rest supine for 20 min in a quiet, temperature-controlled room at 21 .
-Test conducted with subjects in the supine position.
-Artery segment of interest must remain at or below heart level.
-Women should be tested on day 1-7 of the menstrual cycle (i.e., day 7-14 of the ovarian cycle).
-For successive tests, subjects should report at the same time of day to reduce errors associated with circadian variation.
Probe selection -A higher frequency probe (12 MHz) should be used for superficial arteries (e.g., brachial, radial or posterior tibialis).
-A lower frequency probe (7.5 MHz) should be used for deeper arteries (e.g., common femoral).
-The same transducer should be used for all subjects in a given study.
Probe placement -Mark anatomical placement for studies with repeated measurements.
-Use a probe-holding device to maintain image focus.
Ultrasound Settings -Standardize ultrasound global (acoustic output, gain, dynamic range, gamma, rejection) and probe-dependent (zoom factor, edge enhancement, frame averaging, target frame rate) settings.
Artery -Artery selection should be made based on the population of interest, e.g., lower limb arteries should be measured in patients with spinal cord injury.
Diameters (general) -Extend across the entire imaging plane to minimize skewing prior to focusing.
-Use automated or semi-automated image analysis software.
-Use mean or end-diastolic diameters.
Baseline diameters -Collect prior to cuff inflation.
-Subject should hold breath during measurement.
-Collect and average 3 10 sec measurements.
Peak diameters -Capture diameters continuously to ensure true peak diameter.
Blood velocity -The beam-vessel angle must be ≤ 60 .
-Measure continuously.
-Time-averaged maximum velocities are more accurate and reproducible than time-averaged mean velocities.
Shear Stimulus -Shear rate is a suitable substitute for shear stress.
-Diameters and velocities must be captured continuously to estimate shear.
-Shear rates should be presented as an integral, we recommend 40 sec.
-Attention should be paid to secondary flow phenomena, e.g., turbulence and velocity acceleration.
Analysis -Present FMD in absolute (mm) and relative (%) terms.
-Shear rate stimuli should be presented for each research setting.
-Do not normalize FMD to shear rate as a ratio or using ANCOVA.
-HLM can be used to statistically account for shear rate in the evaluation of FMD.
function and health. Most commercial ultrasound machines now provide duplex Doppler functionality; that is, they can simultaneously image and measure blood velocity in conduit arteries in real time.
Arterial Diameter Measurements
Conventionally, two-dimensional brightness mode (B-mode) is used to visualize, in real time, ultrasound echo amplitude distribution in a tomographic plane. Ultrasound wave reflections will only have a prominent amplitude if they originate from acoustic interfaces with a substantial change in acoustic impedance and oriented perpendicular (i.e., at a 90 angle) to the ultrasound beam direction. Therefore, in the cross-sectional view, the lateral segments of the artery wall are blurred, with relatively low amplitude for anterior and posterior lumen-wall transitions. In the longitudinal view, both walls will show up distinctly over a certain range, provided that the arterial segment considered is straight and without branches (Fig. 1) . The transition of the inner layer of the wall, the intima to the lumen, induces a weak signal, while the outer layer, the adventitia, results in reflections with high amplitude. The layer in between, the media, has relatively low reflectivity and appears as a hypo-echoic band in images obtained with ultrasound systems with sufficient resolution.
Measurement Protocol
When imaging a vessel, care should be taken to ensure that the vessel clearly extends across the entire (un-zoomed) plane to minimize the likelihood of skewing the vessel walls. The ultrasound transducer should then be adjusted until the vessel walls appear thickest. Ultrasound global (acoustic output, gain, dynamic range, gamma, rejection) and probe-dependent (zoom factor, edge enhancement, frame averaging, target frame rate) settings should be standardized, especially for a given study. Alterations to probe selection and optimization settings, particularly probe selection, can have a significant impact on measurement precision (unpublished observations). Fig. 4 shows two diameter waveforms, both measured on the same subject within 10 minutes, albeit with different probes (11 MHz and 6.6 MHz); despite all other global and probe-dependent settings being equal, 6.6 mhz resulted in a bias for smaller diameters. To ensure that image focus is maintained and that diameter waveforms are stable, the ultrasound probe needs to be fixed in place using a probe-holding device. The stability of diameter waveforms is also affected by rhythmic breathing patterns; to ensure the optimal quality of diameter waveforms, the subject should ideally hold their breath during recordings.
Probe Selection
Selection of the appropriate ultrasound probe is dependent on the vessel being imaged. The higher the probe frequency, the greater the axial resolution, but this comes at the cost of tissue penetration 28, 29) . The operator should use the highest frequency that has adequate tissue penetration to clearly resolve the structure of interest. For superficial arteries, e.g., brachial, radial and posterior tibialis, a 12 Mhz probe will allow adequate penetration and will provide optimal axial resolution. When imaging deeper arteries, e.g., common femoral, a lower frequency probe (e.g., 7.5 MHz) is recommended; however, the use of a lower frequency probe will yield lower axial resolution, and will limit the capacity to discern small changes in vessel diameter. The same transducer should be used across subjects for a given study to maximize statistical power (Fig. 4) .
Blood Velocity Measurements
Ultrasound assessments of blood velocity have been favorably compared to magnetic resonance imaging, which is capable of higher resolution but is much more costly 30) . With ultrasound, blood velocity is calculated by measuring the Doppler shift, which results from a change in the frequency of a wave due to the motion of the wave source or receiver, or in the case of a reflected wave, the motion of the reflector. The Doppler shift is dependent on the insonating frequency, the velocity of moving blood, and the angle between the sound beam and direction of moving blood, as expressed by the Doppler equation:
where: Df is the Doppler shift frequency (the difference between transmitted and received frequencies), f is the transmitted frequency, v is the blood velocity, q is the angle between the sound beam and the direction of moving blood, and c is the speed of sound. The equation can be rearranged to solve for blood velocity, and this is the value calculated by the ultrasound machine:
Since red blood cells travel at different speeds, even for a small measuring volume, there will be a range of blood velocities for a given unit of time. Per cardiac cycle, Doppler ultrasound systems measure minimum, maximum, and mean blood velocities. The peak velocities represent the fastest moving blood cells flowing through the center of the vessel, whereas mean velocities represent the average speed of blood cells from across the vessel. Mean velocities tend to be limited by incomplete sampling of Doppler shifts across the full width of the artery 31) . Time-averaged maximum velocities are more accurate and reproducible, even though they may lead to overestimations of blood flow by approximately 40% 32) .
Measurement Protocol
Most commercial ultrasound units come equipped with software to automatically calculate blood velocities. These automated calculations are typically limited to each heart beat. When making simultaneous diameter and blood velocity measurements, a compromise has to be made. An optimal B-Mode image is obtained when the ultrasound probe is perpendicular (90 ) to the imaged vessel, whereas an optimal velocity signal is obtained with a beam-vessel angle of ≤ 60 . Errors associated with incorrect estimation of the insonation angle increase exponentially with angles ≥ 60 31) . For further discussion on this topic see Thijssen et al. (2011) 33) .
Measurement Location
For two decades, brachial artery FMD has been widely used as a global endothelial health index 6) ; however, the brachial artery may not adequately characterize global endothelial health for all populations. For instance, given the incidence of CVD following spinal cord injury (SCI), it may be surprising that normal brachial artery FMD has been reported 34) . The current authors previously reported decreased FMD in the legs (posterior tibialis) compared to the arms (radial) in patients with SCI 35) . The retention of upperextremity function likely explains the lack of deterioration of SCI radial arteries. Patients with paraplegia mostly rely on upper-body function for performing daily activities. Since individuals with SCI actively use their upper extremities, blood flow patterns may be such that the blood vessels retain their functional status due to normal shear stressor activity 36, 37) . Notably, we subsequently found that 18 weeks of self-adminis- tered neuromuscular electrical stimulation-induced resistance exercise therapy significantly increased FMD and the arterial range of the posterior tibial artery in male patients with chronic, complete SCI 38) .
Limitations of the Flow-Mediated Dilation Test
Despite its potential, the validity of the FMD test has been questioned due to lack of normalization to the primary stimulus, shear stress [39] [40] [41] [42] . The magnitude of the shear stimulus created with reactive hyperemia is influenced by several factors; subsequently, the shear stimulus may differ significantly among individuals. Therefore, in order to efficaciously compare groups of individuals, the shear stimulus should be considered (see below for further discussion). For instance, Mitchell et al. 40) demonstrated that reduced FMD may be attributable not only to impaired endothelial release of dilatory molecules, but also to less shear stimulus.
Shear Stress Estimation
Clinical studies in humans, including FMD studies, typically estimate shear stress by employing a simplified mathematical model based on Poiseuille's law. More sophisticated approaches are available, but are beyond the reach of most clinical studies since such approaches are not readily available, too expensive, technically challenging and time-consuming [43] [44] [45] . Based on Poiseuille's law, shear stress is calculated as the product of the shear rate and blood viscosity, where the shear rate equals:
where d is the internal arterial diameter, v is the timeaveraged mean blood velocity, and n represents the shape of the velocity profile. For a fully developed parabolic profile, n 2; this is the normal assumption when estimating the shear rate.
Poiseuille's law assumes that: 1) the fluid (blood) is Newtonian; 2) blood flows through a rigid tube; 3) whole blood viscosity represents viscosity at the vessel wall and is linearly proportional to the shear rate; 4) the velocity profile is parabolic. First, although blood is non-Newtonian, the effect of non-Newtonian behavior does not appear to be pronounced in large arteries 46) . Second, blood vessels are distensible, meaning that the wall shear rate may be 30% less in a distensible artery than in a rigid tube 47) . Third, blood viscosity exhibits low intra-subject variability 36) , particularly among a healthy, homogeneous group. Shear rate has been used as a surrogate measure of shear stress in a number of previous studies 36, [48] [49] [50] [51] . Fourth, in arteries, the velocity profile will generally not develop to a full parabola as a consequence of flow unsteadiness and short vessel entrance lengths; however, in the brachial artery, under resting conditions, the underestimation is less pronounced, likely due to a more parabolic velocity profile in this artery, i.e., n (velocity profile) is closer to 2 52) . However, this may only be true for resting conditions; the occurrence of flow turbulence is possible during reactive hyperemia 53) . Despite the aforementioned limitations, shear rate assessments can be reliably made using ultrasound 54) ; however, little attention has been given to the most appropriate blood velocity parameters for calculating the shear rate (see below).
Peak or Integrated Shear Rates?
Recently, we conducted a study to determine which shear rate expression explained the most variation in FMD. Seven shear rate expressions were calculated: peak, change (peak hyperemia minus baseline), integrated over 10, 20, 30, and 40 seconds after tourniquet deflation, and integrated to the peak diameter time 55) . Shear rates integrated for 40 seconds after tourniquet deflation (i.e., post-ischemia) explained the greatest portion of variation for change in diameter; however, the addition of a peak shear rate to a timeintegrated shear rate was significant, suggesting that the peak shear rate may be an additional important independent predictor of FMD. It is worth noting that while peak shear positively correlated with peak diameter when regressed independently, the addition of shear rate integrated over 40 seconds led to a negative relationship between the peak shear rate and peak diameter. A greater peak shear rate for a given integrated shear rate is indicative of a more transitory hyperemic response. A less sustained increase in the shear rate may result in a lower stimulus mechanotransduced to endothelial cells. This study was conducted on young, healthy males; therefore, further study is warranted to confirm these findings in other cohorts.
Importance of the Velocity Profile
The earliest studies investigating the implications of shear stress on endothelial function did so by assessing endothelial cell responses to high versus low shear stress. This was until Davies et al. 56) , in 1986, provided evidence that time-averaged shear stress alone could not explain the pathological behavior of endothelial cells exposed to complex flow patterns. Subsequent studies [57] [58] [59] [60] [61] [62] [63] [64] [65] have shown that vascular endothelial cells respond not only to time-averaged shear stress, but respond differently to different patterns of flow.
The cyclic nature of the beating heart creates pulsatile flow conditions in all arteries. The heart ejects blood during systole and fills during diastole. These cyclic conditions create relatively simple monophasic flow pulses in the upper region of the aorta 66) ; however, pressure and flow characteristics are substantially altered as blood circulates through the arterial tree. Fig. 5 shows an example of a typical brachial artery blood velocity profile. The normal brachial arterial signal is tri-phasic, corresponding to 1) rapid blood flow during systole, 2) initial reversal of blood flow in diastole, and 3) gradual return of forward flow during late diastole.
Complex flow characteristics have a profound impact on the shear stress distribution to which vascular endothelial cells are exposed. While human in vivo studies typically describe shear stress as a mean construct, numerous secondary phenomena associated with flow, including pulsatile flow, retrograde flow, and flow turbulence, can influence the regulation of endothelial cells [67] [68] [69] [70] [71] [72] .
Velocity Acceleration and Endothelial Function
The pulsatile nature of blood flow exposes the endothelial cells to two distinct shear stimuli during the cardiac cycle: a large rate of change in shear at the onset of flow (velocity acceleration), followed by a steady shear component (Fig. 5) . In vitro studies suggest that these two distinct fluid stimuli (velocity acceleration vs. steady shear) regulate short-and longterm endothelial function via independent biomechanical pathways 70, 71, [73] [74] [75] . Studies have shown that the rate of velocity acceleration can affect the progression of atherosclerosis 70, 73, 76) , endothelial cell function 71 , 74) , mechanotransduction 77, 78) , calcium kinetics 79, 80) , and vascular tone 81, 82) . Conditions which affect velocity acceleration include ventricular ischemia 83) , acute myocardial infarction 84) , stenosis 85) , hypertension 86) , and hyperthyroidism 87) . Velocity acceleration is also influenced by aging 86) and physical activity 88, 89) . Recently, we studied the effect of velocity acceleration on FMD in a group of 14 healthy, young, male subjects 90) . FMD was measured prior to and following increases in velocity acceleration (Fig. 5) , which was induced by inflating a tourniquet around the forearm to 40 mmHg. We found that a 14% increase in velocity acceleration attenuated FMD by 11%. This finding suggests that mean blood velocity alone may not adequately characterize the shear stimulus. Attention to secondary flow phenomena may be particularly important when comparing groups with known secondary flow abnormalities.
Statistical Analysis
Studies using the FMD test (i.e., using 5 minutes' ischemia) should consider both time integratedand peak-shear parameters, particularly when attempting to detect differences between experimental groups. Emphasis is placed on 'consider' since the FMD test should not be normalized to the shear rate using conventional approaches. A number of studies have attempted to account for the effect of shear stimulus on FMD by evaluating the quotient of FMD and shear, rather than FMD alone, or by using analysis of covariance (ANCOVA), with shear stimulus as the cofactor 34, 51, [91] [92] [93] [94] . The techniques described above require use of the general linear model (GLM) for determining statistical probabilities associated with the differences found between groups or experimental treatments; however, when using a GLM, the following assumptions must hold true: 1) there must be at least a moderate correlation between the two variables (i.e., shear and FMD), 2) the relationship between shear and diameter must be linear, 3) the intercept of the regression slope must be zero, 4) variance must be similar between groups, and 5) data must be normally distributed 93, 95) . A recent study found that all assumptions for reliable use of shear-diameter ratios were violated 93) . 
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Fig. 5. Acceleration and steady shear components
The normal brachial arterial signal is tri-phasic, corresponding to the: 1) rapid blood flow during systole, resulting in velocity acceleration, 2) initial reversal of blood flow in diastole, and 3) gradual return of forward flow during late diastole, resulting in steady shear component.
Another alternative is to normalize the FMD response (i.e., change in diameter) to shear using hierarchical linear modeling (HLM) 96) . HLM is a more advanced form of multiple linear regression that accounts for hierarchical (i.e., successive inter-related levels) effects on the outcome variable. This is accomplished in HLM by including a complex random subject effect which can appropriately account for correlations among the data. This approach models different patterns in the data by allowing for the intercepts (initial diameter) and slopes (shear rate-diameter) to vary randomly. A third level may also be specified; this may be the specification of groups (e.g., to delineate differences in endothelial function), an intervention, or a modifiable risk factor such as smoking. This approach has been used to compare upper vs. lower extremity arterial health in persons with SCI 35) , to assess improvements in arterial health following electrical stimulation-evoked resistance exercise therapy in persons with SCI 38) , and to assess the effects of occasional cigarette smoking on arterial health 97) . The disadvantage of this approach is that multiple stimuli (preferably ranging from minimal to maximal shear stimuli) are required to generate a reliable shear-diameter relationship.
Improving the Reliability of the FMD Test
The within-subject variability of FMD has been reported to be as low as approximately 50% 98) , which helps to explain why FMD is related to low but not medium or high CVD risk 99) . Within any given study, FMD tests can consistently demonstrate a smaller degree of dilation in subjects with atherosclerotic risk factors versus controls; however, subtle changes in FMD are more difficult to detect. Patients with only one CVD risk factor report FMD values of approximately 7% 100) . For a typical brachial artery with a 4 mm diameter at baseline, this translates to a 0.28 mm increase in diameter. The pixel resolution of a typical ultrasound unit is 0.04 0.04 mm. Measurements of 0.28 mm are within the standard error of measurement. To compound the issue, maximal diameters in response to reactive hyperemia are short lived and therefore hard to capture. Aside from standardizing measurement protocols, measurement reproducibility can be improved by considering the following suggestions.
Automated Diameter Measurements
A number of laboratories are now able to make semi-automated diameter measurements across the cardiac cycle using edge detection software 35, 51, 92, [101] [102] [103] [104] [105] [106] . Studies using edge detection software to estimate FMD have reported intersession coefficients of variation of approximately 11-18% 101, 106, 107) . Traditionally, end-diastolic diameters were used to calculate FMD because: 1) FMD measurements that incorporate nonend-diastolic diameters may introduce measurement errors due to fixed vessel structural issues, and 2) prior to the advent of automated image analysis software, mean diameter measurements were beyond the technical capabilities of most research units. A recent study indicated that calculating FMD based on mean diameters yields comparable results to calculations based on end-diastolic diameters 108) .
Use ANCOVA to Account for Measurable Covariates
FMD can be calculated as: 1) post-only score, 2) change score, 3) fraction (percentage), or 4) co-varied for resting diameter (ANCOVA). A simulation study found the greatest statistical power for the ANCOVA approach out of the four methods listed above, with fraction scores resulting in the lowest power 109) . Expressing FMD as a percentage effectively squares the variation due to resting diameter, and may result in a non-normally distributed statistic from normally distributed data. Using resting diameters as a covariate is most likely to adjust for the bias due to baseline values [109] [110] [111] .
Normalize to the Stimulus
While FMD is certainly attenuated in a number of disease states, FMD may also be "attenuated" if the magnitude of hyperemia 40) or the blood velocity profile is altered, including the rate of velocity acceleration 90) . Further study is required to comprehensively quantify the appropriate expression of the shear stimulus. At present, the shear rate can be calculated as described above and used to normalize to FMD through HLM, but not by using ANCOVA or presenting as a ratio.
Use Multiple FMD Measurements when Possible
The peak diameter in response to reactive hyperemia is short lived and therefore hard to capture (Fig.  3) . Variance in peak diameter measurements may be attributable to differences in the stimulus (i.e., shear stress) or to measurement error (Fig. 6) . Variance due to change in the stimulus can be accounted for by normalizing FMD to shear stress. To account for measurement errors, according to laws governing regression to the mean 112) , the FMD test would need to be repeated multiple times in order to obtain a "true" response. Alternatively, a more accurate assessment of endothelial function can be achieved by estimating shear rate-diameter dose-response curves (Fig. 7) .
Shear Rate: Diameter dose Response Curves
Capturing shear rate-diameter dose-response curves 35, 38, 97, 113) will decrease the likelihood of reaching erroneous conclusions. A standard dose-response curve (Fig. 7) is defined by three parameters: the baseline response (bottom), the maximum response (top), and the slope. The slope (i.e., change in diameter per one unit change in shear rate) would most accurately reflect endothelial function. The maximum response reflects the degree of arterial stiffness 35, 105, 114, 115) . There are a number of advantages to this approach, namely: 1) the stimulus (shear) is directly accounted for in a manner that does not violate statistical assumptions, 2) improved sensitivity, i.e., the slope (endothelial function) can be clearly identified (with the standard FMD test it cannot be ascertained at which point on the slope endothelial function is being estimated), 3) improved reliability, i.e., the dose-response slope is more resistant to measurement error when compared to a single measurement 112) , and 4) more information is provided, i.e., the slope isolates endothelial function whereas the maximum response more likely reflects the degree of arterial stiffness 35, 105, 114, 115) .
Transient versus Steady-State Shear Stress
To overcome the short-lived reactive hyperemia response, and hence short-lived change in diameter, endothelial function can be evaluated by using sustained increases in shear stress, e.g., through local hand warming and low-intensity handgrip exercise 50, 113, 116, 117) . This approach would also allow for more accurate assessment of the shear rate since the assumptions of Poiseuille's law are less likely to be violated (full description provided above).
Recently, we found that the relationship between the shear rate and vasodilatation is comparable when shear rate is increased transiently (ischemia-induced) or in a sustained manner (local hand warming-and handgrip exercise-induced) 55) . This is consistent with a recent study by Pyke et al. 92) , who similarly found a significant relationship between ischemia-induced FMD and handgrip exercise-induced FMD when the FMD responses were normalized to shear rate. Consideration has to be given to the mechanisms inducing FMD; the mechanisms regulating vascular tone may be dependent on the duration of the shear stimulus 81, 116, [118] [119] [120] , with FMD in response to a sustained shear rate likely being less NO-dependent 121) . Nonetheless, the endothelium is still thought to primarily govern vasodilation under steady-state shear rate conditions. For instance, studies have shown that hand warming has no effect on brachial artery diameter when flow is not allowed to rise 48, 50, 116) . Furthermore, pharmacological blockade of the autonomic nervous system has no effect on radial artery FMD in response to hand warming 116) , consistent with animal studies showing that FMD is preserved after surgical or pharmacological denervation 122, 123) . A recent meta-analysis by Inaba et al. 11) , which was subsequently re-analyzed by Green et al. 124) , assessed the CVD prognostic strength of FMD by conducting a meta-analysis of observational studies that examined the association between brachial artery FMD and future cardiovascular events. Green et al. found that FMD resulting from more intense and prolonged shear stimuli using proximal cuff placement, which has been demonstrated to be less NO-de- pendent 121) , provides a better prognosis of CVD risk. Further study is needed to confirm these findings and determine whether FMD in response to sustained increases in the shear rate provides greater prognostic strength for detecting future CVD events.
Conclusions
Assessments of endothelial function offer the potential to predict and track individuals at risk for CVD complications; however, despite the obvious potential, the reliability of this test has been questioned. Recently, a range of practices has been adopted to improve test reliability, including consideration of the shear stimulus and automated diameter measurements; however, the standard approach for inducing shear stimuli, i.e., reactive hyperemia following ischemia, has inherent limitations, namely: 1) the peak diameter in response to reactive hyperemia is short lived and therefore hard to capture, and 2) there is no consensus on the appropriate calculation of shear stress/ rate. These limitations can be overcome with the following strategies: 1) repeat the FMD test multiple times to obtain a more reliable estimate of the "true" response, 2) calculate the shear rate-diameter dose-response to decrease the likelihood of erroneous conclusions, and 3) use sustained increases in shear stress. Further study is required to determine: 1) whether shear-rate diameter dose-response curves offer greater statistical power, 2) whether FMD in response to sustained increases in shear rate provides greater prognostic strength, and 3) the importance of secondary flow phenomena to estimations of the shear rate.
